DK0687295T3 - Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof - Google Patents

Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof

Info

Publication number
DK0687295T3
DK0687295T3 DK94909585T DK94909585T DK0687295T3 DK 0687295 T3 DK0687295 T3 DK 0687295T3 DK 94909585 T DK94909585 T DK 94909585T DK 94909585 T DK94909585 T DK 94909585T DK 0687295 T3 DK0687295 T3 DK 0687295T3
Authority
DK
Denmark
Prior art keywords
cell line
human
lymphoblastoid cell
secreting anti
antibody
Prior art date
Application number
DK94909585T
Other languages
Danish (da)
English (en)
Inventor
Reiko F Irie
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0687295T3 publication Critical patent/DK0687295T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94909585T 1993-02-26 1994-02-09 Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof DK0687295T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/026,320 US5419904A (en) 1990-11-05 1993-02-26 Human B-lymphoblastoid cell line secreting anti-ganglioside antibody
PCT/US1994/001469 WO1994019457A1 (en) 1993-02-26 1994-02-09 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody

Publications (1)

Publication Number Publication Date
DK0687295T3 true DK0687295T3 (da) 2004-04-05

Family

ID=21831157

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909585T DK0687295T3 (da) 1993-02-26 1994-02-09 Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof

Country Status (11)

Country Link
US (1) US5419904A (pt)
EP (1) EP0687295B1 (pt)
JP (2) JP4796682B2 (pt)
AT (1) ATE255633T1 (pt)
AU (1) AU687791B2 (pt)
CA (1) CA2156857C (pt)
DE (1) DE69433378T2 (pt)
DK (1) DK0687295T3 (pt)
ES (1) ES2211877T3 (pt)
PT (1) PT687295E (pt)
WO (1) WO1994019457A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
US5830470A (en) * 1992-09-07 1998-11-03 Kyowa Hakko Kogyo Co., Ltd. Humanized antibodies to ganglioside GM2
US6063379A (en) * 1993-12-09 2000-05-16 Centro De Inmunologia Molecular Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies
AU2735397A (en) * 1996-04-22 1997-11-12 Wistar Institute Of Anatomy And Biology, The Gd2 anti-idiotypic antibodies and uses thereof
EP0975673A2 (en) * 1997-04-21 2000-02-02 Glycozyme, Inc. Determination of recombinant glycosylated proteins and peptides in biological fluids
EP1056861A2 (en) * 1998-02-27 2000-12-06 Novopharm Biotech, Inc. Human monoclonal antibodies capable of oligospecifically recognizing the major tumor-associated gangliosides and methods of use thereof
US6528624B1 (en) * 1998-04-02 2003-03-04 Genentech, Inc. Polypeptide variants
US6194551B1 (en) * 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
PL209786B1 (pl) * 1999-01-15 2011-10-31 Genentech Inc Przeciwciało zawierające wariant regionu Fc ludzkiej IgG1, przeciwciało wiążące czynnik wzrostu śródbłonka naczyń oraz immunoadhezyna
US6737056B1 (en) * 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
US7183387B1 (en) 1999-01-15 2007-02-27 Genentech, Inc. Polypeptide variants with altered effector function
WO2001087302A1 (en) * 2000-05-18 2001-11-22 U.S. Army Medical Research And Material Command Detection of antibodies to squalene in serum
US7824864B2 (en) * 2000-05-18 2010-11-02 The United States Of America As Represented By The Secretary Of The Army Detection of human antibodies to squalene in serum
US20020146753A1 (en) * 2001-04-06 2002-10-10 Henrik Ditzel Autoantibodies to glucose-6-phosphate isomerase and their participation in autoimmune disease
MXPA04003798A (es) * 2001-10-25 2004-07-30 Genentech Inc Composiciones de glicoproteina.
CA2532966C (en) 2003-07-15 2012-12-04 Chugai Seiyaku Kabushiki Kaisha Igm production by transformed cells and methods for quantifying said igm production
ATE518888T1 (de) 2003-10-09 2011-08-15 Chugai Pharmaceutical Co Ltd Stabilisierte lösung mit hoher igm-konzentration
TWI466684B (zh) * 2008-06-30 2015-01-01 Morphotek Inc 抗ｇｄ２抗體及其相關方法及用途
RU2607014C2 (ru) 2011-03-29 2017-01-10 Рош Гликарт Аг Fc варианты антитела
AR092027A1 (es) 2012-07-13 2015-03-18 Roche Glycart Ag Anticuerpos biespecificos anti-vegf/anti-ang-2 y su utilizacion en el tratamiento de enfermedades vasculares oculares
AU2013351292C1 (en) * 2012-11-30 2019-03-28 Katinger Gmbh Recombinant human IgM-antibody effective against cancer cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
DE4107154A1 (de) * 1990-10-11 1992-04-16 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen melanom
US5208146A (en) * 1990-11-05 1993-05-04 The Regents Of The University Of California Murine monoclonal anti-idiotype antibodies
EP0492409A1 (en) * 1990-12-18 1992-07-01 Ishihara Sangyo Kaisha, Ltd. Human monoclonal antibody
WO1993010221A1 (en) * 1991-11-13 1993-05-27 The Regents Of The University Of California Chimeric murine/human anti-idiotype monoclonal antibodies

Also Published As

Publication number Publication date
AU687791B2 (en) 1998-03-05
JP2011209287A (ja) 2011-10-20
EP0687295A1 (en) 1995-12-20
CA2156857C (en) 2006-05-09
JPH08507209A (ja) 1996-08-06
AU6238094A (en) 1994-09-14
DE69433378T2 (de) 2004-10-14
ATE255633T1 (de) 2003-12-15
EP0687295A4 (en) 1997-01-15
WO1994019457A1 (en) 1994-09-01
CA2156857A1 (en) 1994-09-01
US5419904A (en) 1995-05-30
EP0687295B1 (en) 2003-12-03
PT687295E (pt) 2004-04-30
JP4796682B2 (ja) 2011-10-19
DE69433378D1 (de) 2004-01-15
ES2211877T3 (es) 2004-07-16

Similar Documents

Publication Publication Date Title
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
ES2124209T3 (es) Anticuerpos monoclonales mejorados reactivos con caquectina.
ES8801319A1 (es) Un metodo para la deteccion de anticuerpos especificos de un virus lav en un fluido biologico.
GB2236529B (en) Cross-linked antibodies and processes for their preparation
GB2237020B (en) Cross-linked antibodies and processes for their preparation
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
ATE73491T1 (de) Hybridomazellen und deren monoklonale antikoerper gegen den humanen pluropotenten granulozyten- kolonie stimulierenden faktor.
NO174855C (no) Monoklonalt antistoff og cellelinje som produserer dette
ATE151882T1 (de) Karzinomverwandtes haptoglobin (hpr)
ATE71149T1 (de) Monoklonale antikoerper.
EP0190033A3 (en) Monoclonal antibody against a ras oncogene p21 related dodecapeptide
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DK182188A (da) Humant tumorassocieret antigen
BG60169B2 (bg) Получаване на плурипотентен гранулоцитен колоний-стимулиращ фактор
PT76274A (en) Antibodies and antigens useful in the diagnosis and treatment of cancer
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same